RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Hardy Diagnostics in an amount not to exceed $330,000 to procure media, reagents, and supplies for the Clinical Laboratory at Contra Costa Regional Medical Center (CCRMC) for the period from June 30, 2023 through June 30, 2026.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $330,000 over the three-year period and will be fully funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
The CCRMC Clinical Laboratory has used Hardy Diagnostics as a prime resource for prepared bacteriology culture media, reagents and supplies since 2005. The Clinical Lab uses Hardy Diagnostics for its quality and easily obtained media and products used for identification of and sensitivity to antibiotics in patients. This enables staff to treat patients as soon as possible.
|